Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0095
+0.0004 (4.68%)
Dec 22, 2025, 9:30 AM EST
Curative Biotechnology Statistics
Total Valuation
CUBT has a market cap or net worth of 9.28 million. The enterprise value is 12.17 million.
| Market Cap | 9.28M |
| Enterprise Value | 12.17M |
Important Dates
The next estimated earnings date is Thursday, April 16, 2026.
| Earnings Date | Apr 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CUBT has 1.02 billion shares outstanding.
| Current Share Class | 1.02B |
| Shares Outstanding | 1.02B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +3.19% |
| Owned by Insiders (%) | 18.73% |
| Owned by Institutions (%) | n/a |
| Float | 809.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -1.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.42 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 39.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -889,110 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.39% in the last 52 weeks. The beta is 1.29, so CUBT's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -20.39% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 57.76 |
| Average Volume (20 Days) | 292,698 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.96M |
| Pretax Income | -2.94M |
| Net Income | -3.56M |
| EBITDA | -1.87M |
| EBIT | -1.96M |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 218,263 in cash and 3.11 million in debt, giving a net cash position of -2.89 million or -0.00 per share.
| Cash & Cash Equivalents | 218,263 |
| Total Debt | 3.11M |
| Net Cash | -2.89M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -4.99M |
| Book Value Per Share | -0.00 |
| Working Capital | -6.92M |
Cash Flow
| Operating Cash Flow | -946,842 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CUBT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -38.32% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 23, 2010. It was a reverse split with a ratio of 0.02.
| Last Split Date | Aug 23, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |